E-LIB Suche - Ergebnisse für: Fay, Michael P

1

Causal interpretation of the hazard ratio in randomized cli..:

Fay, Michael P ; Li, Fan
Clinical Trials. , 2024

2

Mepolizumab incompletely suppresses clinical flares in a pi..:

Khoury, Paneez ; Makiya, Michelle A. ; Rahim, Rodaba...
Journal of Allergy and Clinical Immunology. 153 (2024) 3 - p. 821-830.e6 , 2024

Link: https://doi.org/10.1016/..

3

Mediation analyses for the effect of antibodies in vaccinat..:

Fay, Michael P. ; Follmann, Dean A.
Journal of Causal Inference. 12 (2024) 1 - p. , 2024

Link: https://doi.org/10.1515/..

4

Durability of Protection Against Coronavirus Disease 2019 (..:

Follmann, Dean ; Mateja, Allyson ; Fay, Michael P...
Clinical Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

5

DON in pediatric cerebral malaria, a phase I/IIA dose-escal..:

Nampota-Nkomba, Nginache ; Nyirenda, Osward M. ; Mallewa, Jane...
Trials. 25 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

6

Reply to Heitjan's commentary:

Fay, Michael P ; Li, Fan
Clinical Trials. , 2024

Link: https://doi.org/10.1177/..

7

Visceral Leishmaniasis–Human Immunodeficiency Virus–Coinfec..:

Singh, Om Prakash ; Chaubey, Rahul ; Kushwaha, Anurag Kumar...
The Journal of Infectious Diseases. 229 (2024) 6 - p. 1909-1912 , 2024

Link: https://doi.org/10.1093/..

8

Association of alpha globin gene copy number with exhaled n..:

Ruhl, A Parker ; Jackson, Jarrett M ; Carhuas, Carlos J...
BMJ Open Respiratory Research. 10 (2023) 1 - p. e001714 , 2023

Link: https://doi.org/10.1136/..

9

A phase 3 randomized crossover trial of plerixafor versus G..:

McDermott, David H. ; Velez, Daniel ; Cho, Elena...
Journal of Clinical Investigation. , 2023

Link: https://doi.org/10.1172/..

10

Assessment of precision in growth inhibition assay (GIA) us..:

Miura, Kazutoyo ; Diouf, Ababacar ; Fay, Michael P....
Malaria Journal. 22 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

11

Examining protective effects of SARS-CoV-2 neutralizing ant..:

Follmann, Dean ; O'Brien, Meagan P. ; Fintzi, Jonathan...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

12

Confidence intervals for prevalence estimates from complex ..:

Bayer, Damon M. ; Fay, Michael P. ; Graubard, Barry I.
Statistics in Medicine. 42 (2023) 11 - p. 1822-1867 , 2023

Link: https://doi.org/10.1002/..

13

A Practical Guide to Exact Confidence Intervals for a Distr..:

, In: Emerging Topics in Modeling Interval-Censored Survival Data; ICSA Book Series in Statistics,

Kim, Sungwook ; Fay, Michael P. ; Proschan, Michael A. - p. 51-78 , 2022

Link: https://doi.org/10.1007/..

14

Vaccine efficacy at a point in time:

Follmann, Dean A ; Fay, Michael P
Biostatistics. 24 (2022) 3 - p. 603-617 , 2022

Link: https://doi.org/10.1093/..

15

Urine eosinophil‐derived neurotoxin: A potential marker of ..:

Makiya, Michelle A. ; Khoury, Paneez ; Kuang, Fei Li...
Allergy. 78 (2022) 1 - p. 258-269 , 2022

Link: https://doi.org/10.1111/..